Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Engineered Nanoparticles Enhance Radiotherapy Effectiveness for Gliomas

Just now September 22, 2026 1 min read 📰 Phys.org
📋 Key Takeaway

Research highlights the role of engineered nanoparticles in enhancing the effectiveness of radiotherapy for gliomas, a significant cancer affecting younger adults. The study focuses on the genetic mutation mIDH1 and its impact on tumor behavior and immune response. This advancement in cancer treatment could have implications for healthcare in Iran, where cancer is a growing concern.

Gliomas are a major cause of cancer-related deaths in younger adults. About 7,000 patients harbor a common genetic mutation that affects the enzyme isocitrate dehydrogenase 1. This mutated enzyme, called mIDH1, can produce a molecule that can reprogram both the tumor cells and the environment in which they grow. The molecule, known as 2-hydroxyglutarate, can also circulate in the blood and reprogram immune cells in the bone marrow.

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →